Skip to main content
Equibles
CNSY logo

CNSY · Cerenome, Inc. · Webcasts, Transcripts & Audio

Track CNSY — free

Use CNSY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CNSY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.60 -0.18 (-10.11%) At close · Oct 2
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These factors raise substantial doubt about the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 14, 2026
Market Cap
$15.10M
Shares
7.59M
Volume · Oct 2 234.62K Avg daily vol (3M) 120.31K

Cerenome, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Cerenome, Inc. (CNSY), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $1.68M −$3.26M '24 Q1 24-05-15 · $1.28M −$2.94M '24 Q2 24-08-14 · $1.46M −$2.87M '24 Q3 24-11-14 · $1.41M −$3.90M '24 Q4 25-03-27 ▲8.7% $1.39M $5.15M '25 Q2 25-08-14 LATEST ▼2.9% $1.03M −$6.95M '26 Q1 26-05-15
Annual General Meeting
Investor event
2026-11-15
Cerenome, Inc. (CNSY) November 2026 Annual General Meeting
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Annual General Meeting
Investor event
2026-11-12
Cerenome, Inc. (CNSY) November 2026 Annual General Meeting
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-15
Cerenome, Inc. (CNSY) Q1 2026 Earnings Call
Revenue
$1.03M
▼ 2.9% YoY
Diluted EPS
$-1.05
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-14
Cerenome, Inc. (CNSY) Q2 2025 Earnings Call
Revenue
$1.39M
▲ 8.7% YoY
Diluted EPS
$-0.16
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-27
Cerenome, Inc. (CNSY) Q4 2024 Earnings Call
Revenue
$1.41M*
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-14
Cerenome, Inc. (CNSY) Q3 2024 Earnings Call Transcript
Positive tone Leptomeningeal metastases (LM) clinical program Rhenium (186Re) Obisbemeda (RNL) dose escalation CNSide diagnostic assay commercialization
Revenue
$1.46M
Diluted EPS
$-0.37
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-14
Cerenome, Inc. (CNSY) Q2 2024 Earnings Call Transcript
Positive tone ReSPECT-LM Trial / Leptomeningeal Program CPRIT Grant Funding CNSide Diagnostic
Revenue
$1.28M
Diluted EPS
$-0.71
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-15
Cerenome, Inc. (CNSY) Q1 2024 Earnings Call Transcript
Positive tone Regulatory and FDA interactions Non-dilutive grant funding strategy ReSPECT-LM Phase I trial
Revenue
$1.68M
Diluted EPS
$-0.75
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-05
Cerenome, Inc. (CNSY) Q4 2023 Earnings Call Transcript
Confident tone FDA interactions and regulatory path ReSPECT-GBM (recurrent glioblastoma) Phase 2 trial CPRIT grant funding and non-dilutive financing
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-10-31
Cerenome, Inc. (CNSY) Q3 2023 Earnings Call Transcript
Diluted EPS
$-1.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-14
Cerenome, Inc. (CNSY) Q2 2023 Earnings Call Transcript
Diluted EPS
$-0.59
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-04-20
Cerenome, Inc. (CNSY) Q1 2023 Earnings Call Transcript
Diluted EPS
$-2.07
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-23
Cerenome, Inc. (CNSY) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-10-20
Cerenome, Inc. (CNSY) Q3 2022 Earnings Call Transcript
Diluted EPS
$-2.85
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-07-21
Cerenome, Inc. (CNSY) Q2 2022 Earnings Call Transcript
Diluted EPS
$-3.56
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-04-21
Cerenome, Inc. (CNSY) Q1 2022 Earnings Call Transcript
Diluted EPS
$-0.19
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
Cerenome, Inc. (CNSY) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-10-21
Cerenome, Inc. (CNSY) Q3 2021 Earnings Call Transcript
Diluted EPS
$-0.28
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-07-22
Cerenome, Inc. (CNSY) Q2 2021 Earnings Call Transcript
Diluted EPS
$-0.25
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-04-22
Cerenome, Inc. (CNSY) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-22
Cerenome, Inc. (CNSY) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-10-22
Cerenome, Inc. (CNSY) Q3 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-10
Cerenome, Inc. (CNSY) Q2 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-14
Cerenome, Inc. (CNSY) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-30
Cerenome, Inc. (CNSY) Q4 2019 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–25 of 25 webcasts
Key facts CIK 1095981 CUSIP 72941H806 13F (30d) 1 filings 1 filers Visit website Investor relations